A Study to Evaluate the Safety and Effectiveness of WF10 Given to Patients With Late-Stage HIV Disease

PHASE3CompletedINTERVENTIONAL
Enrollment

240

Participants

Timeline

Start Date

Not specified

Conditions
HIV Infections
Interventions
DRUG

WF10

Trial Locations (32)

19102

MCP Hahnemann Univ, Philadelphia

20037

George Washington Univ Med Ctr, Washington D.C.

23666

Hampton Roads Med Specialists, Hampton

29206

Burnside Clinic, Columbia

29414

Ludwig Lettau Private Practice, Charleston

30308

AIDS Research Consortium of Atlanta, Atlanta

33136

Univ of Miami School of Medicine, Miami

33602

Hillsborough County Health Dept, Tampa

33609

Ctr for Quality Care, Tampa

35294

Univ of Alabama at Birmingham, Birmingham

48201

Univ Health Ctr, Detroit

52242

Univ of Iowa Hosp & Clinic, Iowa City

55101

Regions Hosp, Saint Paul

60611

Northwestern Univ Med School, Chicago

60612

Rush Med Ctr / Section of Infectious Diseases, Chicago

The CORE Ctr, Chicago

64108

Truman Med Ctr / Infectious Disease Clinic, Kansas City

74114

Associates in Med and Mental Health, Tulsa

87131

Univ of New Mexico Health Science Center, Albuquerque

90048

Tower Infectious Disease Med Ctr, Los Angeles

94103

ViRx Inc, San Francisco

94110

UCSF - San Francisco Gen Hosp, San Francisco

96816

Leahi Hosp / Univ of Hawaii, Honolulu

98101

Virginia Mason Research Center / Clinical Trial Unit, Seattle

946021018

Highland Gen Hosp / San Francisco Gen Hosp, Oakland

02118

Boston Med Ctr / Clinical Research Office, Boston

07114

Newark Community Health Ctr, Newark

Unknown

St Paul's Hosp, Vancouver

QEII Health Science Centre, Halifax

Ottawa General Hospital, Ottawa

Sunnybrook Health Science Ctr, Toronto

Montreal Gen Hosp / Div of Clin Immuno and Allergy, Montreal

All Listed Sponsors
lead

OXO Chemie

INDUSTRY

NCT00002244 - A Study to Evaluate the Safety and Effectiveness of WF10 Given to Patients With Late-Stage HIV Disease | Biotech Hunter | Biotech Hunter